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Abbreviations 
  
                                                          
1
 ABCs, Activities-specific Balance Confidence scale; ANCOVA, analysis of covariance; AP, anteroposterior; 
BMI, Body Mass Index; CL, Controls; f95%, CoP, centre of pressure; frequency below which is 95% of power 
of the acceleration power spectrum; GDS, Geriatric Depression Scale; Hz, Hertz; LEDD, Levodopa Equivalent 
Daily Dose; MDS-UPDRS, Movement Disorder Society version of the Unified Parkinson’s Disease Rating 
Scale; m, slope; mins, minutes; ML, mediolateral; MMSE, Mini Mental State Exam; MoCA, Montreal 
Cognitive Assessment; n, number; ppm, parts per million; PC, Postural Control; PD, Parkinson’s disease; PIGD, 
Postural Instability and Gait Disorder; RMS, Root Mean Square; s, seconds; SD, standard deviation. 
Abstract 
Impaired postural control (PC) is an important feature of Parkinson's disease (PD) but optimal testing 
protocols are yet to be established. Accelerometer-based monitors provide objective measures of PC. 
We characterised time-dependent changes in PC in people with PD and controls during standing, and 
identified outcomes most sensitive to pathology. Thirty-one controls and 26 PD patients were 
recruited: PC was measured with an accelerometer on the lower back for 2 minutes (mins). 
Preliminary analysis (autocorrelation) showed 2 seconds (s) was the shortest duration sensitive to 
changes in the signal; time series analysis of a range of PC outcomes was undertaken using 
consecutive 2s windows over the test. Piecewise linear regression was used to fit the time series data 
during the first 30s and the subsequent 90s of the trial.  
PC outcomes changed over the 2mins, with the greatest change observed during the first 30s after 
which PC stabilised. Changes in PC were reduced in PD compared to controls, and Jerk was found to 
be discriminative of pathology. 
Previous studies focusing on average performance over the duration of a test may miss time-
dependent differences. Evaluation of time-dependent change may provide useful insights into PC in 
PD and effectiveness of intervention. 
Keywords: Postural control; time series; accelerometer; Jerk; Parkinson’s.  
1.0 Introduction 
Postural control (PC) during quiet standing is an important component of clinical evaluation in 
Parkinson's disease (PD), and a cardinal sign of disease staging [9]. Recognising and evaluating 
balance dysfunction is of fundamental importance for managing PD because of the profound impact 
PC has on gait, mobility and falls [36]. The mechanisms underlying balance instability in PD are 
complex, and involve peripheral and central neural structures [36]. Previous research suggests that 
participants with PD even in the early stages exhibit abnormalities in PC measures during quiet 
standing (increased Jerk and root mean square values, decreased frequency) [16,17], and that the 
positive effect of dopaminergic replacement therapy on gait (particularly step hypokinesia and gait 
speed) may not be paralleled for PC where Levodopa has been shown to worsen some outcomes 
[11,31]. Understanding the features of PC especially in the early stage of the disease is therefore 
relevant to the management of PD. 
However, interpretation and clinical inference of PC findings is challenging because testing protocols 
are not standardised.  For example, PC during quiet standing has been routinely used for many years 
[25,20,33,34,36], with variations including: standing with bare feet [25]; with shoes on [8,4,29]; with 
eyes open or closed [25,24]; and with legs spaced a fixed distance and arms crossed on chest [17]. PC 
during quiet stance has also been evaluated over different trial durations ranging from 30 - 120 
seconds [33]. 
More recently body worn accelerometer-based monitors have been used and recommended to 
accurately quantify PC in older adults and people with PD [16,17,19,27,30]. The outcomes 
determined with accelerometers have been shown to be reliable and consistent with those quantified 
from centre of pressure (CoP) data using traditional methods (i.e. force plates) [41], and have the 
additional advantage of yielding rate of change of acceleration (Jerk) which would otherwise require 
multiple derivations of CoP displacement. These monitors also have advantages over traditional 
clinical tests because data are collected continuously over the duration of the test allowing time-
dependent changes in PC to be evaluated. To date PC outcomes are typically summarised over the test 
duration and change over time has not been considered.  This is a methodological issue that needs to 
be addressed because time-dependent fluctuation may provide a more subtle reflection of PC 
adaptations in addition to averaged values.  
The aim of this study was to characterise time-dependent changes in a broad range of PC outcomes 
derived from an accelerometer over 2 minutes of quiet standing using a novel method of analysis. We 
compared the time dependence difference in early PD and older adults and aimed to identify the 
outcomes of PC most sensitive to pathology. We hypothesised that: 1) PC would change over the 
duration of a 2 minute test; 2) the greatest change would be observed in the early stage of the test in 
order to stabilise PC; and finally 3) stabilisation of PC (determined by time-dependent change) would 
be less efficient in PD compared to age matched controls. 
  
2.0 Experimental procedures 
PD participants and healthy age-matched controls (CL) were recruited from the larger Incidence of 
Cognitive Impairment in Cohorts with Longitudinal Evaluation – Parkinson’s Disease Gait study 
(ICICLE-PD GAIT) [13], which aimed to recruit all new cases of parkinsonism from secondary care 
services in Newcastle upon Tyne and Gateshead from June 1, 2009, to December 31, 2011. 
 
2.1 Participants 
Participants were assessed during their visit to the Clinical Ageing Research Unit, Newcastle 
University. Participants were excluded if they had any neurological (other than PD), orthopaedic or 
cardiothoracic conditions that may have markedly affected their walking or safety during the testing 
sessions. In addition, PD participants had to be diagnosed with idiopathic PD according to the UK 
Parkinson’s Disease Brain Bank criteria and were excluded if they presented with significant memory 
impairment (Mini Mental State Exam (MMSE) < 24 [6]), dementia with Lewy bodies, drug induced 
parkinsonism, ‘vascular’ parkinsonism, progressive supranuclear palsy, multiple system atrophy, 
corticobasal degeneration or poor command of English. 
This study was conducted according to the declaration of Helsinki and had ethical approval from the 
Newcastle and North Tyneside research ethics committee. All participants signed an informed consent 
form prior to testing. 
 2.2. Demographic and clinical measures 
Age, sex and body mass index (BMI) were recorded for each participant. Cognition was assessed with 
the MMSE and the Montreal Cognitive Assessment (MoCA) [26]. Depression was evaluated with the 
Geriatric Depression Scale (GDS) [37]; physical fatigue was assessed using the Multidimensional 
Fatigue Inventory (MFI) [38]; and balance self-efficacy was measured using the self-rated Activities-
specific Balance Confidence scale (ABCs) [28]. The severity of PD motor symptoms in the PD 
participants was measured using the Hoehn and Yahr scale [9], which ranges from 0 (no symptoms) to 
5 (wheelchair bound or bedridden if unaided) and section III of the modified Movement Disorder 
Society version of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS [7]), which ranges 
from 0 (no motor symptoms) to 132 (severe motor symptoms). The Postural Instability and Gait 
Disorder (PIGD) and Tremor phenotype subscales were also calculated from the MDS-UPDRS [39]. 
Levodopa equivalent daily dose (LEDD) scores were calculated according to established methods 
[40]. 
 
2.3. Standing balance test 
Participants were instructed to start from a standing position, with their feet positioned within the 
boundaries of a predefined area (400 mm wide × 600 mm long),  to place the hands by their sides 
[29], and to maintain an upright standing position for 2 minutes while looking straight ahead. Similar 
to previous studies, participants wore their shoes during the test with no restriction with regard to foot 
placement [24]. The recording of data started 3 seconds after participant acknowledged they 
understood what was required of them. Each subject performed one test, in line with previous 
recommendations [41], and to avoid familiarisation to the assessment and fatigue [22,3]. PD 
participants who were on medication were tested approximately 1 hour after medication intake. 
 
2.4 Equipment 
PC was measured with a single tri-axial accelerometer-based monitor
2
 (resolution 0.976mg, clock 
accuracy: ±20parts per million (ppm)) located on the lower back (5
th
 lumbar vertebra, L5, Figure 1). 
The device is small (6.0 × 21.5 × 31.5mm) and lightweight (9.0g) with no external wiring which has 
been validated for its suitability in capturing high-resolution data akin to human movement [14]. Data 
were sampled at a rate of 50 Hertz (Hz) in order to have consistency with previous literature [17] and 
downloaded to a computer once recording was complete. The accelerometer was attached directly to 
the skin with the aid of a hydrogel adhesive
3
 and covered with a Hypafix
4
 bandage for extra support.  
 
Figure 1. 
Experimental set up: the site of attachment and orientation of the tri-axial accelerometer device on the lower 
back (L5). In dark grey x (vertical) axis, in black y (mediolateral) axis, and in light grey z (anteroposterior) axis.  
 
2.5 Data processing and analysis 
Once data were downloaded to a computer they were analysed by a bespoke MATLAB
®
 (R2012a) 
program. Of particular interest were the accelerations in the mediolateral and anteroposterior planes as 
quiet standing balance is reflected in these directions [17]. Data were filtered using a 4
th
 order zero 
phase, low pass Butterworth filter with a cut-off frequency of 3.5Hz [17]. In accordance with previous 
work [17], data were transformed to a horizontal-vertical coordinate system [21] before extracting the 
following outcomes for the mediolateral (ML), anteroposterior (AP) and combined directions, which 
have been shown to be valid, reliable, and sensitive to early PD [17,16,19]: 
                                                          
2
 Axivity AX3, York, UK 
3
 PAL Technologies, Glasgow, UK 
4
 BSN Medical Limited, Hull, UK 
1. Jerk: the rate of change of acceleration, a measure of the smoothness of PC [17]; 
2. Root mean square (RMS): magnitude of the acceleration traces [23,17]; 
3. Frequency: the frequency below which is 95% of power of the acceleration power spectrum 
(f95%) [17] was evaluated using both the fft and the cumsum MATLAB functions (Figure 2); 
4. Ellipsis: the area including the 95% of the ML and AP acceleration trajectories [27] was 
evaluated using the eig and prod MATLAB functions (Figure 2). 
 
 
Figure 2. 
(a): example frequency evaluation along mediolateral direction (f95%ML), in grey the power spectrum, in black 
dotted line the obtained result. 
(b): example of ellipsis evaluation: in grey accelerometer signal on the y – z (mediolateral (ML)-anteroposterior 
(AP)) axis plane, in black the ellipsis graphical representation corresponding to the area including the 95% of 
the acceleration trajectories along ML and AP directions. 
 
2.6 Data considerations  
To examine time-dependent changes in PC, it was first important to identify the shortest duration of 
time within the 2 minutes test that was sensitive to changes in acceleration signal. To do this we used 
autocorrelations of squared values of the acceleration traces and squared first-derivative of the 
acceleration traces (the precursors of RMS and Jerk values, respectively). Averaged autocorrelation 
values showed that a 2 second bout was optimal with correlation values dropping to zero after no 
more than a lag of 100 samples (2 seconds), this choice took also into account the frequency 
components of the signal [2]. Therefore outcomes for PC strategies were calculated during 
consecutive non-overlapping 2 second windows (i.e. 0-2 seconds, 2-4 seconds, …, 118-120 seconds). 
Figure 3 ((a)-(d)) describes the process used to extract data showing accelerometer raw data, 
autocorrelation and examples of clinical outcomes. All variables except for the f95% were normalised 
by duration of the bout length (2 seconds). 
 
2.7 Statistical analysis 
The process of data analysis corresponded with our hypotheses, as outlined below: 
Hypothesis 1: Between group differences for each PC outcome were evaluated over the 60 
consecutive 2 second bouts using repeat-measures analysis of covariance (ANCOVA). Group (CL vs. 
PD) was entered as a between-person factor and time (consecutive 2 second windows) as a within-
person factor. Age and sex were included as covariates. ANCOVA revealed no significant group 
differences; however significant main effects of time for RMS indicated PC outcomes were non-
stationary and justified examining how PC changed over time. 
Hypothesis 2: Inspection of data and preliminary analysis based on consecutive bouts of 30 seconds 
(0-30s, 30s-60s, 60s-90s, 90-120s) revealed that time-dependent changes in PC occurred mostly in the 
first 30 seconds for both CL and PD, and no significant changes were found between PD and CL data 
for the last 3 bouts (30-60s, 60-90s, 90-120s). To formally test whether most change would occur 
during the first 30 seconds of the standing test, piecewise linear regression was fitted to data from the 
first 30 seconds (0-30 seconds) and subsequent 90 seconds (30-120 seconds) of the standing test. 
Hypothesis 3: Differences in the slopes (m) of the regression lines between the 0-30 second and the 
30-120 second sections were then tested using ANCOVA with group (PD, CL) as between-person 
factor, time section (0-30 seconds, 30-120 seconds) as a within-person factor, and age and sex as 
covariates. Data analysis was carried out using SPSS v19 (IBM). 
 
Figure 3. 
(a): an example of corrected and filtered data extracted from a subject with Parkinson’s disease during a two 
minutes quiet standing test. In black y axis (mediolateral) data, and in grey z axis (anteroposterior) data. (b): 
example of autocorrelation signal. (c): example of Jerk time series extracted from the accelerometer signal using 
a 2 second window. (d): example of RMS time series extracted from the accelerometer signal using a 2 second 
window. 
3.0 Results 
Participant demographic, clinical and cognitive descriptors are shown in Table 1. Compared to CL, 
participants with PD were aged matched; included proportionally less women (CL: 45%, PD: 23%); 
presented with lower balance confidence; poorer cognition; and increased fatigue and depression 
(although the depression scores remained within the normal range). Participants with PD were in the 
early stages of the disease with mild motor symptoms. PC was shown to vary over time (time and 
time × group effects were found, see Table 3) with changes occurring in the first 30 seconds of the 
test in CL, but not PD. A summary of the piecewise linear regressions are shown in Figures 2-4 and 
data relating to the slopes for the first 30 seconds and the subsequent 90 seconds are shown in Table 
2. 
Table 1. 
Clinical and demographic characteristics for control participants (CL), and people with Parkinson’s disease 
(PD). 
Characteristic 
CL (n = 31) 
Mean (SD) 
PD (n = 26) 
Mean (SD) 
p 
Male/female (n) 17/14 20/6 .080 
Age (years) 67.6 (7.5) 67.2 (11.1) .859 
MMSE (0 – 30) 29.3 (1.0) 28.5 (1.0) .024 
MoCA (0 – 30) 27.7 (1.8) 24.5 (3.1) <.001 
GDS (0 – 15)  1.2 (1.7) 2.4 (1.8) .016 
MFI Physical fatigue (0 – 20) 8.5 (3.8) 10.3 (3.0) .055 
ABCs (0 – 100%) 91.7 (12.1) 83.5 (17.7) .052 
Hoehn & Yahr stage: HYI, HYII (n) - 9, 17 - 
MDS-UPDRS III (0 – 132) - 
26.1 (10.3) 
- 
Motor Phenotype (n) - 
PIGD 9 
ID 2 
TD 15 
- 
Levodopa Equivalent Daily Dose (mg/day) - 169.42 (141.9) - 
Group means have been adjusted for age and sex differences between groups; MMSE: Mini Mental State Exam; MoCA: 
Montreal Cognitive Assessment; GDS: Geriatric Depression Scale; MFI – Multidimensional Fatigue Inventory; ABCs: 
Activities specific balance confidence scale; UPDRS: Unified Parkinson’s Disease Rating Scale; PIGD: Postural instability 
and gait disorder phenotype; ID: indeterminate phenotype; TD: Tremor dominant phenotype. p difference between CL and 
people with PD. In bold significant p-values (p <0.05).  
3.1 Differences in PC in PD and controls averaged over 2 minutes. 
Between group differences (PD vs. CL) for each of the four PC measures evaluated using the average 
value of the time series from 2 second bout windows showed no difference between PD and CL for 
Jerk values (combined, ML or AP) (Figure 4 (a)-(c)). For PD participants, combined RMS was 
significantly greater than controls (p = 0.049), while RMS AP was marginally higher (p = 0.057), and 
RMS ML comparable (p = 0.444) (Figure 4 (d)-(f)). Ellipsis and f95% AP and ML values were 
comparable for PD and CL participants (Figure 4 (g)-(i)). 
 
3.2 Time-dependent changes in PC in PD and CL. 
The values of the slopes of the regression lines used to fit the data during the first 30 seconds (0-30 
seconds) and the subsequent 90 seconds (30-120 seconds) of the standing test are shown in Figure 3 
(panel (c) and (d)).  ANCOVA analysis revealed a significant main effect of time for all outcomes 
apart from Jerk ML and f95% AP.  There was also a time × group interaction for both Jerk and Jerk 
ML (Table 3) whereby CL decreased their total Jerk and Jerk ML more than PD participants during 
the first 30 seconds. In contrast Jerk remained stable in both groups over the last 90 seconds (Figure 4 
(a)-(c)). 
 
  
Table 2. 
Values of the slopes (m) for each accelerometers outcome. Values are shown as Mean (SD). Significant (p 
<0.05) Time Effect (between sections, ǂ) and Time × Group Effect (٭) of the ANCOVA analysis for the linear 
regression slopes results (m) are shown for each variable. 
 
 
Table 3. 
Results of the ANCOVA analysis for the linear regression slopes (m) results using a 30 seconds cut-off: p values 
of Time Effect (between sections, ǂ) and Time × Group Effect (CL vs. PD,٭) are reported for each variable, in 
bold are shown the significant p values (p <0.05). 
 
Variable ǂ Time Effect 
٭Time × Group 
Effect 
Jerk m ǂ٭ 0.021 0.013 
Jerk AP m ǂ 0.006 0.560 
Jerk ML m ٭ 0.108 0.020 
RMS m ǂ 0.001 0.092 
RMS AP m ǂ 0.008 0.103 
RMS ML m ǂ 0.001 0.238 
f95%AP m 0.132 0.137 
f95%ML m ǂ 0.004 0.982 
Ellipsis m ǂ 0.015 0.074 
Variable 
Section 1: 0-30 seconds Section 2: 30-120 seconds 
CL 
n = 31 
PD 
n = 26 
CL 
n = 31 
PD 
n = 26 
Jerk m (deg·10
-2
) ǂ٭ -0.3193 (0.600) -0.0176 (0.003) -0.0005 (.100) -0.0246 (0.100) 
Jerk AP m (deg·10
-2
) ǂ -0.1575 (0.200) -0.0565 (0.002) -0.0006 (0.030) -0.0131 (0.030) 
Jerk ML  m (deg·10
-2
) ٭ -0.1618 (0.500) 0.0390 (0.003) 0.0005 (0.040) -0.0115 (0.100) 
RMS  m (deg·10
-2
) ǂ -0.2736 (0.400) -0.0997 (0.003) 0.0158 (0.100) 0.01985 (0.100) 
RMS AP m (deg·10
-2
) ǂ -0.2552 (0.400) -0.0724 (0.003) 0.0132 (0.100) 0.0201 (0.100) 
RMS ML m (deg·10
-2
) ǂ -0.0684 (0.100) -0.0403 (0.001) 0.0007 (0.020) 0.0002 (0.020) 
f95% AP m (deg·10
-2
) 2.5346 (8.100) -0.8517 (8.989) -0.4956 (2.100) -0.7702 (1.800) 
f95% ML m (deg·10
-2
) ǂ 2.8111 (8.300) 3.4203 (7.725) -0.5034 (1.200) -0.5181 (2.600) 
Ellipsis m (deg·10
-2
) ǂ -0.0484 (0.100) -0.000153 (0.001) 0.0004 (0.010) -0.0003 (0.001) 
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Figure 4. 
Mean time series data using a 2 second (s) window for Jerk (a), Jerk along anteroposterior direction (AP) (b), Jerk along mediolateral direction (ML) (c), RMS (d), RMS 
along anteroposterior direction (AP) (e), RMS along mediolateral direction (ML) (f), Ellipsis (g), f95% along anteroposterior direction (AP) (h), and f95% along mediolateral 
direction (ML) (i),  considering effect of pathology (Control participants (CL) vs. people with Parkinson’s disease (PD)). Results from linear regression using a 30 second 
cut-off are overlapped.  
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4.0 Discussion 
The specific aim of this study was to characterise time-dependent change in PC in participants with 
early PD compared to age-matched CL and identify the outcomes most sensitive to pathology. To date 
this is the largest study examining PC in PD and healthy older controls (n = 57) with an instrumented 
balance test (previous studies ranged on average from n = 19 to n = 40 [2,16-19,27]). The novel 
findings of this study were that PC changes during the first 30 seconds of a test in healthy controls 
after which it is maintained, in contrast to PD who did not show early time-dependent change in PC. 
These findings were in contrast to values averaged over the duration of the test. The findings support 
our hypotheses and suggest that time-dependent changes in PC may identify subtle changes in PC 
missed when reporting average performance and should also be considered.  
 
4.1 Time-dependent changes in PC and effect of pathology. 
We hypothesised that PC would show time-dependent change over the duration of a 2 minute test and 
would be greatest in the early stage of the test as PC is stabilised. Furthermore, time-dependent 
change would be reduced in PD compared to age-matched controls.  Our results confirm these 
hypotheses.  PC changed over the course of 2 minutes quiet standing with the greatest change 
observed in the first 30 seconds and was different in PD and CL. Controls showed a reduction in PC 
outcomes during the first 30 seconds of the PC test in contrast to PD participants who did not 
demonstrate change over time (as evident by Jerk, RMS and ellipsis), which suggests less adaptive PC 
strategies overall. 
When average values were compared over the 2 minute test, although participants with PD showed 
higher values with respect to CL, no significant difference was found between the groups except for 
RMS. These findings are in contrast to previous studies [17,16] however this may be explained by 
differences in the characteristics of the PD participants and subtle differences in methodology 
(constrained versus non-constrained stance).  
When time dependant changes were examined (slopes of the linear regression of the first 30 seconds 
vs. those of the last 90 seconds) PD and CL participants showed differences in PC outcomes during a 
static PC test  [16,17], which is not surprising given the effect of PD pathology on motor control 
 
 
16 
 
[36,12]. Differences were more evident in the ML than AP direction, which concurs with findings 
from two previous studies [31,27].   
Our results therefore show the need to inspect time-dependent change over the first 30 seconds in 
order to depict between-group difference rather than examine values for each discrete 2 second bout 
windows as the analysis from the 2 minutes standing test revealed that pooled data were not sensitive 
to pathology (RMS only was found to differentiate between CL and participants with PD). 
 
4.2 Sensitivity of outcome measures of PC. 
With respect to the measurement of PC, we found that Jerk was the most sensitive outcome which for 
combined directions discriminates between CL and participants with PD. In contrast with Mancini et 
al. 2011[17] we did not find differences in relation to RMS, f95%, ellipsis and Jerk in the AP 
direction. This again may be due to differences in methodology adopted and clinical characteristics of 
the participants (who were untreated in contrast to our study). We also found that PC characteristics in 
the ML direction were more sensitive than in the AP direction. This may reflect a decrease in postural 
tone at the trunk and hip levels, which would decouple the trunk from lower limb sway [31], whereas 
a reduced sway in AP direction might reflect the increase stooped position mainly consisting in 
flexion of the hips and knees which is often observed in more advanced PD [31,36]. These results 
concur with the view that adaptation takes place over time through motor learning but this is less 
effective for people with PD.  
 
4.3 Substrates of PC underlying time-dependent change. 
Time-dependent changes in PC for all groups in our study occurred in the first 30 seconds of the test, 
suggesting early stabilisation before reaching a plateau. This is supported by literature which suggests 
motor learning underpins fast and effective adjustment of postural responses to change in position, 
which is then followed by a period of stabilisation [12,35]. Differences in PC strategies in PD may be 
due to both abnormal spatiotemporal coordination of muscles’ postural responses which are often 
hypometric (small) in people with PD and a decreased ability to generate and sustain PC as a result of 
biomechanical [12] and impaired sensory-motor integration as shown by previous studies [1,15,5]. 
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Moreover and in agreement with published literature [36], the difficulty to choose and maintain a 
postural strategy may reflect an important role of the voluntary motor control mediated by the basal 
ganglia which is impaired in PD. This concurs with the view that adaptation takes place over time 
through motor learning but this is less effective for participants with PD and further inhibited by 
medication even in the early stage of the disease [31,27]. 
 
4.4 Implications for clinical testing. 
The time-dependent changes in PC observed in this study has implications for test protocols. The 
early stage of the test appears to be critical to examine postural adaptation and a 30 second trial is 
likely to be sufficient to capture this.  Data collected after this time period reflects a stable state of PC. 
Most protocols use average values masking these early changes which could provide additional 
important information with respect to the influence of disease severity and intervention [16,19,17,31].  
Furthermore, the ability to stabilise PC rather than maintain a static state most likely reflects 
requirement for real world postural stability. 
The consequence of impaired PC includes restricted functional mobility, reduction in levels of daily 
physical activity, and the onset of falls [10].  Tentative implications for the management of early PD 
therefore arise from this study. If PC is refractory to dopaminergic replacement therapy even in the 
early stages of disease onset when response to medication is optimal [11,18], early efforts need to be 
directed towards ameliorating PC deficit. Furthermore, rehabilitation strategies that focus on 
improved directional control (mediolateral) and aim to enhance more rapid stabilisation may be 
important to improve stabilisation and enhance PC in early PD. Early intervention is also warranted 
before secondary, compensatory change becomes more evident [32]. Therefore we propose that our 
novel methodology has the potential to be adopted as a “tool” to understand the effect of pathology, 
efficacy of new pharmacological, surgical and physical interventions and provide insight into time 
dependant PC mechanisms which may have not been examined so far. 
 
4.5 Limitations. 
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These results are preliminary and further examination in a larger cohort is needed to determine 
whether these results can be confirmed, in addition examination of other pathologies will allow us to 
determine whether these time-dependant changes are specific to PD. Future work will examine PC 
strategies, effect of test protocol (shoes/no shoes, eyes open/closed), and effect of disease severity due 
to follow up time points in the larger incident PD cohort compared to age matched controls (ICICLE-
PD GAIT).  
 
5.0 Conclusions 
Time-dependent adjustments in PC occur in the first 30 seconds of quiet standing and are less 
efficient in PD suggesting poorer adaptive PC.  Testing conditions for examining time-dependent 
changes in PC therefore require a minimum of 30 seconds to reflect postural adaptation. Time-
dependent differences in stability also appear to be greater in the mediolateral direction with Jerk the 
most sensitive outcome to discriminate between groups.  Rehabilitation strategies that focus on 
mediolateral control may be optimal for improving balance in people with PD and should be started 
early. In future our methodology could be applied to various pathologies which affect balance, 
providing insight into PC strategies with respect to pathology and response to intervention. 
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